In 2017, half of all reimbursed drug prescriptions, 78 million items, were redeemed by people over the age of 65, according to Mr Bence Retvari, the State Secretary of the Ministry of Human Capacities.
Speaking in parliament, Mr Retvari said that the National Health Insurance Fund (NEAK) paid HUF 149.3bn (€460.2m) to reimburse these products, whereas elderly patients spent HUF 63bn (€194m) on their medicines. Data collected by the Central Statistics Office (KSH) show that with regard to the 65-69 and 70-75 age groups the figures were very similar: the reimbursement amounts came to HUF 44.8bn (€138.1m) and HUF 39.4bn (€121.4m) respectively, and private expenditure to HUF 16.5 (€50.9m) and HUF 15.5bn (€47.8m). However, over 74 years costs have risen significantly, with a reimbursement figure of HUF 65.1bn (€200.7m), and a private spending figure of HUF 30.9bn (€95.2m).
In 2017, HUF 477.3bn (€1.5bn), in gross consumer prices, was spent on reimbursed drugs in Hungary. 71% of the total cost, HUF 352.7bn (€1.1bn), was covered by the National Health Insurance Fund (NEAK) in the form of reimbursement.